Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach

Langendijk, 2008, Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy, J Clin Oncol, 26, 3770, 10.1200/JCO.2007.14.6647

Mrozek, 2005, Survivorship and complications of treatment in breast cancer, Clin Adv Hematol Oncol, 3, 238

Egawa, 2001, Toxicity and health-related quality of life during and after high dose rate brachytherapy followed by external beam radiotherapy for prostate cancer, Jpn J Clin Oncol, 31, 541, 10.1093/jjco/hye115

Murata, 2008, Impact of short-course radiotherapy and low anterior resection on quality of life and bowel function in primary rectal cancer, Am J Surg, 195, 611, 10.1016/j.amjsurg.2007.12.034

Jensen, 2006, The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires, Radiother Oncol, 78, 298, 10.1016/j.radonc.2006.02.005

Trott, 2012, Biological mechanisms of normal tissue damage: importance for the design of NTCP models, Radiother Oncol, 105, 79, 10.1016/j.radonc.2012.05.008

Deasy, 2010, Radiotherapy dose-volume effects on salivary gland function, Int J Radiat Oncol Biol Phys, 76, S58, 10.1016/j.ijrobp.2009.06.090

Werner-Wasik, 2010, Radiation dose-volume effects in the esophagus, Int J Radiat Oncol Biol Phys, 76, S86, 10.1016/j.ijrobp.2009.05.070

Gagliardi, 2010, Radiation dose-volume effects in the heart, Int J Radiat Oncol Biol Phys, 76, S77, 10.1016/j.ijrobp.2009.04.093

Rancati, 2010, Radiation dose-volume effects in the larynx and pharynx, Int J Radiat Oncol Biol Phys, 76, S64, 10.1016/j.ijrobp.2009.03.079

Marks, 2010, Radiation dose-volume effects in the lung, Int J Radiat Oncol Biol Phys, 76, S70, 10.1016/j.ijrobp.2009.06.091

Michalski, 2010, Radiation dose-volume effects in radiation-induced rectal injury, Int J Radiat Oncol Biol Phys, 76, S123, 10.1016/j.ijrobp.2009.03.078

Stuschke, 2012, Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans, Radiother Oncol, 104, 45, 10.1016/j.radonc.2012.03.017

Efstathiou, 2012, Adjuvant radiation therapy for early stage seminoma: proton versus photon planning comparison and modeling of second cancer risk, Radiother Oncol, 103, 12, 10.1016/j.radonc.2012.01.012

Wolff, 2012, Irradiation with protons for the individualized treatment of patients with locally advanced rectal cancer: a planning study with clinical implications, Radiother Oncol, 102, 30, 10.1016/j.radonc.2011.10.018

Schwarz, 2011, Helical tomotherapy and intensity modulated proton therapy in the treatment of early stage prostate cancer: a treatment planning comparison, Radiother Oncol, 98, 74, 10.1016/j.radonc.2010.10.027

Moon, 2009, Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy, Radiother Oncol, 90, 66, 10.1016/j.radonc.2008.09.027

van der Laan, 2013, Rococo cooperative group. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: a planning comparative study, Acta Oncol, 52, 561, 10.3109/0284186X.2012.692885

Van de Water, 2011, The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature, Oncologist, 16, 366, 10.1634/theoncologist.2010-0171

Van de Water, 2011, Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer, Int J Radiat Oncol Biol Phys, 79, 1216, 10.1016/j.ijrobp.2010.05.012

Roelofs, 2012, ROCOCO Consortium. Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer, J Thorac Oncol, 7, 165, 10.1097/JTO.0b013e31823529fc

Roelofs, 2010, Design of and technical challenges involved in a framework for multicentric radiotherapy treatment planning studies, Radiother Oncol, 97, 567, 10.1016/j.radonc.2010.08.009

Aleman, 2003, Long-term cause-specific mortality of patients treated for Hodgkin’s disease, J Clin Oncol, 21, 3431, 10.1200/JCO.2003.07.131

Darby, 2013, Risk of ischemic heart disease in women after radiotherapy for breast cancer, N Engl J Med, 368, 987, 10.1056/NEJMoa1209825

Henson, 2013, Radiation-related mortality from heart disease and lung cancer more than 20years after radiotherapy for breast cancer, Br J Cancer, 108, 179, 10.1038/bjc.2012.575

Bentzen, 2008, Randomized controlled trials in health technology assessment: overkill or overdue?, Radiother Oncol, 86, 142, 10.1016/j.radonc.2008.01.012

Christianen, 2012, Predictive modelling for swallowing dysfunction after primary (chemo) radiation: results of a prospective observational study, Radiother Oncol, 105, 107, 10.1016/j.radonc.2011.08.009

Egelmeer, 2011, Development and validation of a nomogram for prediction of survival and local control in laryngeal carcinoma patients treated with radiotherapy alone: a cohort study based on 994 patients, Radiother Oncol, 100, 108, 10.1016/j.radonc.2011.06.023

Dehing-Oberije, 2010, Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients, Radiother Oncol, 97, 455, 10.1016/j.radonc.2010.09.028

Peeters, 2006, Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling, Int J Radiat Oncol Biol Phys, 66, 11, 10.1016/j.ijrobp.2006.03.034

De Ruysscher, 2012, Radiation-induced oesophagitis in lung cancer patients. Is susceptibility for neutropenia a risk factor?, Strahlenther Onkol, 188, 564, 10.1007/s00066-012-0098-z

Beetz, 2012, NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors, Radiother Oncol, 105, 101, 10.1016/j.radonc.2012.03.004

Beetz, 2012, External validation of three dimensional conformal radiotherapy based NTCP models for patient-rated xerostomia and sticky saliva among patients treated with intensity modulated radiotherapy, Radiother Oncol, 105, 94, 10.1016/j.radonc.2011.11.006

Beetz, 2012, Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: the role of dosimetric and clinical factors, Radiother Oncol, 105, 86, 10.1016/j.radonc.2011.05.010

Vergeer, 2009, Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program, Int J Radiat Oncol Biol Phys, 74, 1, 10.1016/j.ijrobp.2008.07.059

Nutting, 2011, PARSPORT trial management group. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial, Lancet Oncol, 12, 127, 10.1016/S1470-2045(10)70290-4

van Elmpt, 2012, Should patient setup in lung cancer be based on the primary tumor? An analysis of tumor coverage and normal tissue dose using repeated positron emission tomography/computed tomography imaging, Int J Radiat Oncol Biol Phys, 82, 379, 10.1016/j.ijrobp.2010.09.016

Schwartz, 2013, Adaptive radiotherapy for head and neck cancer-dosimetric results from a prospective clinical trial, Radiother Oncol, 106, 80, 10.1016/j.radonc.2012.10.010

McGowan, 2013, Treatment planning optimisation in proton therapy, Br J Radiol, 86, 255545, 10.1259/bjr.20120288

Lomax, 2008, Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions, Phys Med Biol, 53, 1043, 10.1088/0031-9155/53/4/015

Lomax, 2008, Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: the potential effects of calculational uncertainties, Phys Med Biol, 53, 1027, 10.1088/0031-9155/53/4/014

Unkelbach, 2009, Reducing the sensitivity of IMPT treatment plans to setup errors and range uncertainties via probabilistic treatment planning, Med Phys, 36, 149, 10.1118/1.3021139

Pommier, 2010, Simulating demand for innovative radiotherapies: an illustrative model based on carbon ion and proton radiotherapy, Radiother Oncol, 96, 243, 10.1016/j.radonc.2010.04.010